China NMPA Product Recall - Absorbable internal fixation for fractures

Zimmer Biomet (Shanghai) Medical International Trading Co., Ltd. has initiated a voluntary Class II recall of its absorbable internal osteofixators for fractures. This action, reported on December 6, 2021, by the National Medical Products Administration (NMPA) and the Shanghai Municipal Drug Administration, addresses a significant product safety concern. The core issue identified is the risk of excessive bacterial endotoxin levels in certain product batches, directly linked to deficiencies within the manufacturing process. Operating under stringent Chinese regulatory frameworks, Zimmer Biomet is required to uphold high quality and safety standards. The Class II recall classification signifies that the use of the product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. The company is actively retrieving the affected devices, with specific model, specification, and batch details provided in the "Medical Device Recall Event Report Form." This recall underscores the company's dedication to patient safety and compliance with NMPA regulations.